Pharmatest signs deal to exploit Taconic’s humanized mouse models for bone cancer research

2017-07-06 08:42:00

Researchers are hopeful that this new model will address incurable and painful diseaseBy Team ABLEUS-based Taconic Biosciences has signed a collaborative agreement with Pharmatest Services to leverage the company’s oncology and skeletal disease preclinical efficacy services using Taconic’s humanized mouse models.Taconic Biosciences is a fully-licensed, global leader in genetically engineered r

Read more

Dr Tedros Adhanom Ghebreyesus assumes office as WHO Director-General

2017-07-03 20:34:33

Dr Tedros Adhanom Ghebreyesus assumed office as Director-General of the World Health Organization, succeeding Dr Margaret ChanBy Team ABLEOn July 1, 2017, Dr Tedros Adhanom Ghebreyesus assumed office as Director-General of the World Health Organization, succeeding Dr Margaret Chan, who has held office since January 1, 2007.The Director-General is WHO\'s chief technical and administrative officer a

Read more

GSK to exploit Artificial Intelligence for drug discovery; strikes deal with Exscientia

2017-07-03 20:33:18

Pre-clinical collaboration focused on up to 10 targets nominated by GSKBy Team ABLEExscientia, the company that provides Artificial Intelligence (AI)-driven drug discovery solutions, has entered into a strategic drug discovery collaboration with pharma major GlaxoSmithKline (GSK). During this collaboration, Exscientia will apply its AI enabled platform and combine this with the expertise of GSK, i

Read more

New clues found to common respiratory virus; discovery provides potential target for vaccines, treatments

2017-07-03 20:31:30

Researchers at Washington University School of Medicine in St. Louis, have found clues to how RSV causes disease.By Team ABLEBy age 2, most children have been infected with respiratory syncytial virus (RSV), which usually causes only mild cold symptoms. But people with weakened immune systems, such as infants and the elderly, can face serious complications, including pneumonia and -- in some cases

Read more

Revita Life Sciences decides to continue study on brain dead subjects

2017-07-03 20:28:40

Revita Life Sciences has announced that it is continuing to advance its multi-modality clinical intervention in the state of brain death in humans.By Team ABLERevita Life Sciences, a biotechnology company focused on translational regenerative therapeutic applications, has announced that it is continuing to advance its multi-modality clinical intervention in the state of brain death in humans.“We

Read more

DBT posts proposal call for India-UK Industrial Waste Challenge 2017

2017-07-03 20:19:10

In the recent proposal call, Department of Biotechnology of India (DBT) has called upon Indian organizations to apply for funding to work with UK partners on biotechnology solutions for industrial waste challenges in India.By Team ABLEIn the recent proposal call, Department of Biotechnology of India (DBT) has called upon Indian organizations to apply for funding to work with UK partners on biotech

Read more

Energy startup Carbon Masters secures funding from IAN and Sangam Ventures to scale-up bottled bio-CNG production

2017-07-03 20:17:37

Carbon Masters was founded in 2012, and the company is known to have developed India’s first bottled bio-CNG brand called Carbonlites. Carbonlites is bio-CNG produced from the biomethanisation of organic waste streams.By Team ABLEIn an announcement released yesterday, it is revealed that Carbon Masters, the Bengaluru-located renewable energy solutions provider, has raised an undisclosed amount o

Read more

Dr Harsh Vardhan launches National Biopharma Mission (i3)

2017-06-30 00:21:34

The first ever Industry-Academia mission to accelerate biopharmaceutical development in India was formally launched by the Union Cabinet Minister for Science and Technology, Earth Sciences, Environment, Forests and Climate Change, Dr. Harsh Vardhan in New Delhi on June 30, 2017. By Team ABLEThe program named Innovate in India (i3) will witness an investment of USD 250 million with USD 125 million

Read more

DBT calls for proposals from colleges under strengthening component of Star College Scheme

2017-06-28 09:30:23

The program, according to DBT, emphasizes holistic improvement of science education at undergraduate level with special emphasis on practical training to students. By Team ABLEThe Department of Biotechnology has invited applications from colleges of all the states and union territories of India offering undergraduate education in Sciences under ‘Star College’ Scheme to brand and nurture excell

Read more

DBT announces Innovative Young Biotechnologist Award (IYBA) for year 2017

2017-06-28 09:29:26

The Department of Biotechnology instituted the ‘Innovative Young Biotechnologist Award’ (IYBA) in the year 2005. This is an attractive, career oriented scheme to identify and nurture outstanding young scientists with innovative ideas and desirous of pursuing research in frontier areas of biotechnology. \n\n\n \n \n \n \n\n\n

Read more